会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • 6-Phenyl-4H-v-triazolo[1,5-a][1,4]benzodiazepines
    • 6-苯基-4H-哒嗪-3-基){8,1-a {9 {8 1,4 {9 benzodiazepines
    • US3943145A
    • 1976-03-09
    • US427167
    • 1973-12-20
    • Andre GagneuxRoland HeckendornRene Meier
    • Andre GagneuxRoland HeckendornRene Meier
    • C07D487/04
    • C07D487/04C07C247/00
    • Compounds of the class of 6-phenyl-4H-v-triazolo[1,5-a][1,4] benzodiazepines, which in the 3-position are unsubstituted or substituted, particularly by a carbamoyl group or a substituted carbamoyl group, their 5-oxides and their pharmaceutically acceptable acid addition salts have valuable pharmacological properties and are active ingredients for therapeutic compositions. In particular, these new compounds have an anticonvulsive and anti-aggressive action. Specific embodiments are N,N-dimethyl-6-phenyl-8-chloro-4H-v-triazolo [1,5-a][1,4]benzodiazepine-3-carboxamide and N,N-dimethyl-6-(o-fluorophenyl)-8-chloro-4H-v-triazolo [1,5-a][1,4]benzodiazepine-3-carboxamide.
    • 6-苯基-4H-v-三唑并[1,5-a] [1,4]苯并二氮杂类化合物,其3-位未被取代或被取代,尤其是氨基甲酰基或取代的氨基甲酰基取代, 其5-氧化物及其药学上可接受的酸加成盐具有有价值的药理学性质,并且是治疗组合物的活性成分。 特别地,这些新化合物具有抗惊厥和抗侵袭作用。 具体实施方案是N,N-二甲基-6-苯基-8-氯-4H-哒嗪并[1,5-a] [1,4]苯并二氮杂-3-甲酰胺和N,N-二甲基-6-(o - 氟苯基)-8-氯-4H-哒嗪并[1,5-a] [1,4]苯并二氮杂-3-甲酰胺。
    • 7. 发明授权
    • Triazole derivatives
    • US4209516A
    • 1980-06-24
    • US938623
    • 1978-08-31
    • Roland HeckendornRene Meier
    • Roland HeckendornRene Meier
    • C07D249/08A61K31/41C07D249/10C07D401/06C07D413/06
    • C07D249/08
    • The present invention relates to new triazole derivatives of the formula ##STR1## wherein R.sub.1 represents hydrogen, lower alkyl, optionally esterified or etherified hydroxymethyl, formyl, optionally functionally modified carboxy, or optionally mono- or disubstituted aminomethyl,R.sub.2 represents lower alkyl, and R.sub.3 represents hydrogen or lower alkyl, whereby R.sub.2 and R.sub.3 as lower alkyl can be bound directly, or in .beta.- or .gamma.-position also by way of oxygen, sulphur or the imino radical or a lower alkylimino radical, and the rings A and B independently of each other can be unsubstituted or substituted, and to their addition salts with inorganic and organic acids, in particular the pharmaceutically acceptable acid addition salts. These new compounds possess valuable pharmacological properties. In particular they have an anti-convulsive activity and are useful for the treatment of epilepsy and of conditions of tension and of agitation. Specific embodiments are 1-[2-(o-chlorobenzoyl)-4-chlorophenyl]-5-(morpholinomethyl)-1H-1,2,4-triazole-3-carboxamide,1-[2-(o-chlorobenzoyl)-4-chlorophenyl]-5-[(dimethylamino)-methyl]-1H-1,2,4-tariazole-3-carboxamide, N-methyl-1-[2-(o-chlorobenzoyl)-4-chlorophenyl]-5-(morpholinomethyl)-1H-1,2,4-triazole-3-carboxamide, N-ethyl-1-[2-(o-chlorobenzoyl)-4-chlorophenyl]-5-(morpholinomethyl)-1H-1,2,4-triazole-3-carboxamide, N-ethyl-1-[2-(o-chlorobenzoyl)-4-chlorophenyl]-5-[(dimethylamino)-methyl]-1H-1,2,4-triazole-3-carboxamide, N-propyl-1-[2-(o-chlorobenzoyl)-4-chlorophenyl]-5-[(dimethylamino)-methyl]-1H-1,2,4-triazole-3-carboxamide, N,N-dimethyl-1-[2-(o-chlorobenzoyl)-4-chlorophenyl]-5-[(dimethylamino)-methyl]-1H-1,2,4-triazole-3-carboxamide, and N,N-dimethyl-1-[2-(o-fluorobenzoyl)-4-chlorophenyl]-5-[(dimethylamino)-methyl]-1H-1,2,4-triazole-3-carboxamide.
    • 8. 发明授权
    • Heterocyclic S-imino-S-oxides
    • 杂环S-亚氨基-S-氧化物
    • US4045570A
    • 1977-08-30
    • US575319
    • 1975-05-07
    • Gunther DorhoferRoland HeckendornErich SchmidAngelo StorniArmin Zust
    • Gunther DorhoferRoland HeckendornErich SchmidAngelo StorniArmin Zust
    • C07D337/14C07D495/04
    • C07D495/04C07D337/14
    • The invention relates to new heterocyclic S-imino-S-oxides of the formula I ##STR1## in which one of the symbols X.sub.1 and X.sub.2 denotes a direct bond and the other denotes the vinylene group --CH=CH-- or the epithio radical --S--, Y.sub.1 and Y.sub.2 conjointly denote an additional bond or one of the symbols denotes hydrogen and the other denotes hydrogen or, conjointly with the symbol R.sub.1 or R.sub.2, which is present on the same carbon atom, denotes the oxo radical, one of the symbols R.sub.1 and R.sub.2 denotes hydrogen or lower alkyl and the other denotes hydrogen or lower alkyl or, conjointly with the symbol Y.sub.1 or Y.sub.2, which is present on the same carbon atom, denotes the oxo radical, or, if Y.sub.1 and Y.sub.2 conjointly denote an additional bond, also denotes lower alkoxy, and R.sub.3 and R.sub.4 independently of one another denote hydrogen, halogen up to atomic number 35, lower alkyl, lower alkoxy or trifluoromethyl and R.sub.5 denotes hydrogen or lower alkyl, and to their acid addition salts in particular the pharmaceutically with inorganic and organic acceptable acid addition salts. These new compounds possess valuable pharmacological properties. In particular they have an anticonvulsive activity and are useful for the treatment of epilepsy and of states of tension and states of agitation.
    • 本发明涉及式I(I)的新的杂环S-亚氨基-S-氧化物,其中符号X1和X2之一表示直接键,而另一个表示亚乙烯基-CH = CH-或 环氧基-S-,Y1和Y2共同表示另外的键,或者一个符号表示氢,另一个表示氢,或与存在于同一碳原子上的符号R 1或R 2结合表示氧代基, 符号R1和R2中的一个表示氢或低级烷基,另一个表示氢或低级烷基,或与存在于同一碳原子上的符号Y1或Y2结合表示氧代基,或者如果Y1和Y2 并且表示低级烷氧基,R3和R4彼此独立地表示氢,卤素直至原子数为35,低级烷基,低级烷氧基或三氟甲基,R5表示氢或低级烷基,并且表示其酸加成盐 特别是药物中含有的 有机和有机可接受的酸加成盐。 这些新化合物具有宝贵的药理学特性。 特别是它们具有抗惊厥活性,并且可用于治疗癫痫和张力状态和搅动状态。
    • 9. 发明授权
    • Diazepine derivatives
    • 二氮杂衍生物
    • US4027029A
    • 1977-05-31
    • US535480
    • 1974-12-23
    • Andre GagneuxRoland HeckendornRene Meier
    • Andre GagneuxRoland HeckendornRene Meier
    • A61K31/55A61K31/41A61K31/445A61K31/495A61K31/535
    • A61K31/55
    • Compounds of the class of 6-phenyl-4H-s-triazolo[1,5-a][1,4]benzodiazepine-2-carboxamides, their 5-oxides and their pharmaceutically acceptable acid addition salts have valuable pharmacological properties and are active ingredients for therapeutic compositions. In particular, these new compounds have an anti-convulsive and anti-aggressive action and inhibit somatic reflexes. Specific embodiments are N,N-dimethyl-6-phenyl-8-chloro-4H-s-triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide, 6-(o-fluorophenyl)-8-chloro-4H-s-triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide, N,N-dimethyl-6-(o-fluorophenyl)-8-chloro-4H-s-triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide and N,N-dimethyl-6-(o-chlorophenyl)-8-chloro-4H-s-triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide.
    • 6-苯基-4H-s-三唑并[1,5-a] [1,4]苯并二氮杂-2-甲酰胺类化合物,其5-氧化物及其药学上可接受的酸加成盐具有有价值的药理学性质并且是活性的 治疗组合物的成分。 特别地,这些新化合物具有抗惊厥和抗侵袭作用并抑制体细胞反射。 具体实施方案是N,N-二甲基-6-苯基-8-氯-4H-s-三唑并[1,5-a] [1,4]苯并二氮杂-2-甲酰胺,6-(邻氟苯基)-8- 5-氯-4H-三唑并[1,5-a] [1,4]苯并二氮杂-2-甲酰胺,N,N-二甲基-6-(邻氟苯基)-8-氯-4H-三唑并[1 ,5-a] [1,4]苯并二氮杂-2-甲酰胺和N,N-二甲基-6-(邻氯苯基)-8-氯-4H-三唑并[1,5-a] 4]苯并二氮杂-2-甲酰胺。